Testing ways to treat hepatitis B in rural Africa

This trial is testing three different treatment approaches for people with hepatitis B in rural Ethiopia. Researchers want to find the simplest and most effective way to provide antiviral therapy — medicine that stops the virus from damaging the liver — in areas where hospitals and laboratories are limited. The study compares three models: one that treats only patients with specific warning signs, one that treats almost everyone, and one that treats all hepatitis B-positive patients.

In Ethiopia and other low-income countries, most people with hepatitis B never receive treatment, even though the medication works well and can prevent serious liver damage and death. This trial exists to figure out which treatment approach works best in rural areas where resources are scarce, so that more people can access life-saving care.